Product logins

Find logins to all Clarivate products below.


Dana Edwards

Senior Vice President, Sales and Marketing

Dana Edwards is the Senior Vice President of Sales and Marketing at Clarivate, where she leads global sales, commercial strategy, sales enablement, sales operations and marketing for the company’s Life Science and Healthcare portfolios.

With over two decades of experience, Dana has held leadership roles across the full spectrum of the life sciences ecosystem—including sponsors/pharma manufacturers, clinical research sites, CROs, and eClinical technology providers. Her career includes 8.5 years at IQVIA (formerly IMS Health), where she helped shape commercial strategies and drive growth across global markets.

Dana’s experience spans molecule to market, making her one of the few commercial executives with such a broad, cross-vertical perspective. She is known for her ability to align sales and marketing functions to deliver measurable impact, foster long-term client relationships, and support innovation through data-driven decision-making.

Her leadership is defined by a deep understanding of customer needs, a passion for collaboration, and a commitment to delivering value across the entire product lifecycle.

Dana holds a Bachelor of Science in Biochemistry from the University of North Carolina at Chapel Hill.

Latest news

Partner news August 17, 2026
ShanghaiRanking’s Academic Ranking of World Universities 2026 Press Release

The 2026 Academic Ranking of World Universities (ARWU) is released today by ShanghaiRanking Consultancy. Since 2003, ARWU has been presenting the world’s top universities annually based on transparent methodology and…

Partner news
News August 13, 2026
Clarivate and KYBORA Partner to Help Biopharma Companies Execute Strategic Transaction Outcomes

This collaboration combines the scientific and commercial expertise of Clarivate’s Life Sciences & Healthcare Consulting practice with KYBORA’s global transaction execution capabilities to accelerate life sciences transactions London, U.K., August…

News August 12, 2026
Clarivate Enhances SkyRiver to Help Libraries Share, Reuse and Create Trusted Metadata

Combining community metadata sharing, institutional choice and AI-powered record creation LONDON, UK, August 12, 2026 – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.